Clinical Trial Update: Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study

View source ↗

Summary

Marketing approval has been granted for the PET radiotracer [11C]Choline (C-11 Choline) to detect recurrent prostate cancer, based on data from an expanded-acce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• C-11 Choline (Carbon-11 choline)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cancer of the Prostate | Status: APPROVED_FOR_MARKETING